ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

OCTN2 Activates a Non-Canonical Carnitine Metabolic Pathway to Promote MASH-HCC Progression and Immunotherapy Resistance.

Chuqi Xia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.